Stock analysts at Benchmark assumed coverage on shares of Semler Scientific (NASDAQ:SMLR - Get Free Report) in a research report issued on Tuesday, MarketBeat Ratings reports. The firm set a "buy" rating and a $101.00 price target on the stock. Benchmark's price objective suggests a potential upside of 159.31% from the company's current price.
Separately, Wall Street Zen downgraded shares of Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.
Read Our Latest Report on Semler Scientific
Semler Scientific Stock Down 3.7%
NASDAQ SMLR opened at $38.95 on Tuesday. The business has a fifty day moving average price of $36.68 and a two-hundred day moving average price of $42.35. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.52 and a quick ratio of 0.51. Semler Scientific has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The stock has a market capitalization of $434.29 million, a PE ratio of -14.92 and a beta of 1.39.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
Institutional Trading of Semler Scientific
A number of institutional investors and hedge funds have recently bought and sold shares of SMLR. BNP Paribas Financial Markets acquired a new stake in Semler Scientific in the fourth quarter valued at $30,000. Summit Securities Group LLC acquired a new stake in Semler Scientific in the first quarter valued at $32,000. Jones Financial Companies Lllp acquired a new stake in Semler Scientific during the 4th quarter worth about $34,000. SBI Securities Co. Ltd. grew its holdings in Semler Scientific by 161.3% during the 1st quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock worth $35,000 after acquiring an additional 592 shares during the period. Finally, Larson Financial Group LLC acquired a new stake in Semler Scientific during the 4th quarter worth about $38,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
